Patent Yard Sign in
Expired Canadian patentCanada

Structural carotenoid analogs for the inhibition and amelioration of disease

CA 2495167 C · Owner: Nadolski, Geoff · Inventors: Lockwood, Samuel Fournier; Hix, Laura M.; O'Malley, Sean

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method for inhibiting and/or ameliorating the occurrence of diseases associated with reactive oxygen species reactive nitrogen species, radicals , and/or non-radicals in a subject whereby a subject is administered a carotenoid structural analog, either alone or in combination with another carotenoid analog, or co-antioxidant formulation. The analog or analog combination is administered such that the subject's risk of experiencing diseases associated with reactive oxygen species reactive nitrogen species, radicals and/or non-radicals may be thereby reduced. The analog or analog combination may be administered to a subject for the inhibition and/or amelioration of …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 29, 2003 and granted August 21, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 29, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 29, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 29, 2003
GrantedAugust 21, 2018
Term endedJuly 29, 2023
Patent numberCA 2495167 C
Classification (IPC)C07C403/24 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedJuly 29, 2003Patent grantedAug 21, 2018Term endedJuly 29, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.